We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Molgen Presents Diagnostics Chemistry, Flows and Systems at MEDICA 2021

By LabMedica International staff writers
Posted on 15 Nov 2021

MolGen B. More...

V. (Veenendaal, Netherlands) presented its diagnostics chemistry, flows and systems at MEDICA 2021, the largest medical trade fair in the world that has been taking place for more than four decades. Over the years, the event has attracted several thousand exhibitors from more than 50 countries. Leading individuals from the fields of business, research, and politics attended MEDICA 2021, alongside tens of thousands of national and international experts and decision-makers from the sector. MolGen took advantage of the opportunity to connect with the global leaders in clinical chemistry, molecular diagnostics, translational medicine, lab management, and other areas of breaking science in laboratory medicine.

At MEDICA 2021, MolGen showcased and demonstrated its latest products and services, including technology, systems, reagents and consumables for human diagnostics and pharmaceutical sciences. MolGen demonstrated its PurePrep 96 automated DNA and RNA purification system which is suitable for high throughput workflows with up to 96 samples per run and process samples up to 1ml. The device uses magnetic separation technology for different matrices like blood, cultured cells, bacteria, tissues, cell-free body fluids, and plant samples. The small-footprint system enables high-speed, high-quality processing with magnetic rods used to transfer magnetic beads through the various purification phases of mixing, binding, washing and elution resulting in purified DNA and RNA.

MolGen also showcased its PurePrep TTR high throughput automated liquid handling device that transfers liquid fast, accurately, and consistently from tubes to Deep Well microtiter plates. Both the tubes and plates are equipped with barcodes read by scanners to track and trace samples throughout the complete workflow. This system is developed to decrease the hands-on time, increase the lab’s accuracy, reduce contamination risks by decapping and capping tubes, and transfer samples from the tubes to plates. It is optimized for processing PurePrep TL+ samples.

Additionally, MolGen highlighted its PurePrep FR automated liquid handler for filling plates with high precision and decreasing hands-on time. It is ideal for downstream processing setups, like the PCR and LAMP setup. This system is easy to adjust to different procedures and provides insight into the results. Also on display was the MolGen Sealer, a semi-automatic thermal sealer which is ideal for low to medium throughput laboratories that requires uniform and consistent sealing of micro-plates. Unlike manual plate sealing, the MolGen Sealer produces consistent plate seals. With flexible temperature, time and pressure settings, the sealing conditions are easily optimized to guarantee consistent results, produce 100% tight seals, and eliminate sample loss or evaporation. Offering complete versatility, the MolGen Sealer is compatible with a full range of plates for PCR, assay or storage applications, and can be used with plates ranging from standard height to deep well.

Related Links:
MolGen B.V.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.